Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (Nasdaq: TMCI) is a medical technology company that develops and sells surgical products for bunion and related foot and ankle deformities. Its portfolio centers on the Lapiplasty 3D Bunion Correction System, which combines instruments, implants and surgical methods to correct bunions in… From the company’s description.
Over the twelve months to Sep 30, 2026, Treace Medical Concepts, Inc. reported revenue of $203.35M, down 7.1% from a year earlier, and a net loss of $55.79M. Its operating margin was −24.4%, and operations used $8.74M in cash. In fiscal 2025, it reported revenue of $212.69M, up 1.6% from fiscal 2024, and a net loss of $59.00M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Treace Medical Concepts, Inc. does
In the company’s own words
Treace Medical Concepts, Inc. (Nasdaq: TMCI) is a medical technology company that develops and sells surgical products for bunion and related foot and ankle deformities. Its portfolio centers on the Lapiplasty 3D Bunion Correction System, which combines instruments, implants and surgical methods to correct bunions in three dimensions and stabilize the underlying joint. Other products include the Adductoplasty midfoot correction system, Nanoplasty and Percuplasty minimally invasive bunion systems, SpeedMTP great toe fusion implants, the SpeedPlate fixation platform, IntelliGuide patient-specific planning and cut guides, and products for hammertoe and other foot procedures. The company’s customers include podiatric and orthopaedic foot and ankle surgeons, hospitals and ambulatory surgery centers; it sells in the United States through employee sales representatives, independent sales agencies and stocking distributors. Employee sales representatives generated approximately 80% of revenue in 2025, and its field sales fleet included 297 team members at year-end. The company was founded around its Lapiplasty technology and has expanded into midfoot correction and broader foot and ankle products. Its website is www.lapiplasty.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- PONTE VEDRA, FL
- Fiscal year end
- December
- CIK
- 1630627
- SIC
- 3841
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Treace Medical Concepts, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Treace Medical Concepts, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Treace Medical Concepts, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Treace Medical Concepts, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Treace Medical Concepts, Inc.'s last four quarterly filings that the numbers alone won't show?”